Takeda Grows Immuno-Oncology Portfolio With $525m Maverick Acquisition

Japanese Pharma Exercises Option Under 2017 Deal

 
• By Alaric DeArment
  
Takeda
Takeda has exercised its option to acquire Maverick Therapeutics for $525m, expanding its IO development business. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip